Sequential injection of anti-HER2 scFv antibody-modified HchrR6 mRNA-loaded exosomes and CNOB led to the specific activation of CNOB and subsequent MCHB generation at tumor site, causing near-complete inhibition of orthotopic HER2-positive BT474 xenografts [56]. The gene discussed is ERBB2; the disease is neoplasm.